Cutaneous Melanoma

1. Epidemiology and Prevention of Melanoma

   1. Acquired Precursor Lesions and Phenotypic Markers of Increased Risk for Cutaneous Melanoma

      • Cristian Navarrete-Dechent, Alon Scope, Hensin Tsao, Nadeem G. Marghoob, Arthur J. Sober, Ashfaq A. Marghoob

      Pages 501-524

   2. Melanoma Prevention and Screening

      • Susan M. Swetter, Alan C. Geller, Sancy A. Leachman, John M. Kirkwood, Alexander Katalinic, Jeffrey E. Gershenwald

      Pages 525-570

2. Management of Primary Melanoma and Locoregional Metastases

   1. Front Matter

      Pages 571-571

      PDF

   2. Treatment of Primary Melanomas

      • John F. Thompson, Michael A. Henderson, Gabrielle Williams, Merrick I. Ross

      Pages 573-594

   3. Reconstructive Options Following Surgery of Primary Melanoma

      • Marc Moncrieff, Brian Gastman, Rogerio Izar Neves, Howard Peach, Anthony P. Tufaro

      Pages 595-656

   4. Axillary and Epitrochlear Lymph Node Dissection for Melanoma

      • Sandra L. Wong, Douglas S. Tyler, Charles M. Balch, John F. Thompson, Kelly M. McMasters

      Pages 657-667

   5. Inguinofemoral, Iliac/Obturator, and Popliteal Lymphadenectomy for Melanoma

      • Keith A. Delman, Lesly A. Dossett, Clara R. Farley, Kelly M. McMasters, Omgo E. Nieweg

      Pages 669-687

   6. Neck Dissection and Parotidectomy for Melanoma

      • Brian Gastman, Rebecca Knackstedt, Ryan P. Goepfert, Baran Sumer, Ashok Shaha, Michael E. Kupferman

      Pages 689-704

   7. Local and Recurrent Regional Metastases of Melanoma

      • Matthew C. Perez, Kenneth K. Tanabe, Charlotte E. Ariyan, John T. Miura, Dorotea Mutabdzic, Jeffrey M. Farma et al.

      Pages 705-737

   8. Radiotherapy for Primary and Regional Melanoma

      • Angela M. Hong, Graham Stevens

      Pages 739-745

   9. Adjuvant Systemic Therapy for High-Risk Melanoma Patients

      • Yana G. Najjar, Ryan Massa, Vernon K. Sondak, Alexander M. M. Eggermont, Helen Gogas, John M. Kirkwood

      Pages 747-766

   10. Neoadjuvant Systemic Therapy for High-Risk Melanoma Patients

       • Emily Z. Keung, Rodabe N. Amaria, Vernon K. Sondak, Merrick I. Ross, John M. Kirkwood, Jennifer A. Wargo

       Pages 767-793

   11. Hyperthermic Regional Perfusion for Melanoma of the Limbs

       • Douglas S. Tyler, Douglas L. Fraker, Harald J. Hoekstra, H. Richard Alexander Jr.

       Pages 795-825

   12. Isolated Limb Infusion for Melanoma

       • Georgia Marie Beasley, John T. Miura, Jonathan S. Zager, Douglas S. Tyler, John F. Thompson, Hidde M. Kroon

       Pages 827-850

   13. Surveillance and Follow-Up of Melanoma Patients

       • Rachael L. Morton, Anne Brecht Francken, Mbathio Dieng

       Pages 851-866

   14. Local Melanoma Recurrence, Satellitosis, and In-transit Metastasis: Incidence, Outcomes, and Selection of Treatment Options

       • John F. Thompson, Nicola Mozzillo, Merrick I. Ross

       Pages 867-894

3. Uncommon Presentations of Melanoma

   1. Front Matter

      Pages 895-895

      PDF

   2. Acral Lentiginous Melanoma

      • Yukiko Teramoto, Hector Martinez-Said, Jun Guo, Claus Garbe

      Pages 897-924

   3. Lentigo Maligna Melanoma

      • Cristian Navarrete-Dechent, Kelly C. Nelson, Anthony M. Rossi, Erica H. Lee, Christopher A. Barker, Kishwer S. Nehal et al.

      Pages 925-951

   4. Mucosal Melanoma

      • Michael A. Henderson, Charles M. Balch, Claus Garbe, Alexander N. Shoushtari, Bin Lian, Chuanliang Cui et al.

      Pages 953-968

Written by the leading melanoma experts from the United States, Australia, and Europe, this new edition incorporates the clinical outcomes of more than 70,000 patients treated at major melanoma centers throughout the world and is the definitive and most authoritative textbook on melanoma used worldwide. Providing the most up-to-date and comprehensive information needed for the clinical management and scientific study of melanoma, Cutaneous Melanoma, 6^th edition covers everything from precursors of melanoma to advanced stages of metastatic disease. 

• cutaneous melanoma
• melanoma staging
• pathology of melanoma
• radiotherapy for melanoma
• skin cancer

• Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA

  Charles M. Balch

• Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, USA

  Michael B. Atkins

• Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany

  Claus Garbe

• Departments of Surgical Oncology and Cancer Biology, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, USA

  Jeffrey E. Gershenwald

• Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA

  Allan C. Halpern

• Departments of Medicine, Dermatology, and Translational Science, University of Pittsburgh and UPMC Hillman Cancer Center, Pittsburgh, USA

  John M. Kirkwood

• Divisions of Cancer Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, Australia

  Grant A. McArthur

• Melanoma Institute Australia, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

  John F. Thompson

• Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, USA

  Arthur J. Sober

Dr. Charles M. Balch, M.D., FACS, Professor of Surgery, University of Texas Southwestern Medical Center, was previously Deputy Director for Clinical Trials and Outcomes Research at Johns Hopkins Institute and Executive Vice President and Chief Executive Officer of American Society of Clinical Oncology (ASCO). He has led a distinguished career as a clinical and academic oncologist for the past 35 years, as a leading authority in both melanoma and breast cancer. He has also made significant contributions to laboratory research in tumor immunology and human T lymphocyte differentiation. He is author of over 700 publications, which have been cited over 20,000 times in the biomedical literature, and has lectured in over 35 different countries in the world and most of the major academic centers in the United States. Dr. Balch is the founding Editor-in-Chief of the Annals of Surgical Oncology (Springer), which is recognized as the leading journal in the world in its field. He also held major leadership roles involving clinical research in three comprehensive cancer centers (University of Alabama at Birmingham, University of Texas M D Anderson, and the City of Hope National Medical center).

Jeffrey Gershenwald, MD, University of Texas, MD Anderson Cancer Center, Surgical Oncology
John Thompson, MD, Melanoma Institute of Australia, Surgical Oncology 
Michael Atkins, MD, Georgetown Medical Center, Medical Oncology
John Kirkwood, MD, University of Pittsburgh, Medical Oncology
Arthur Sober, MD, Harvard Medical Center, Dermatology
Allan Halpern, MD, Memorial Sloan Kettering, Dermatology
Claus Garbe, University Hospital, Tuebingen, Dermatology

Policies and ethics